Compare IMTX & DEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMTX | DEA |
|---|---|---|
| Founded | N/A | 2011 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 2020 | 2014 |
| Metric | IMTX | DEA |
|---|---|---|
| Price | $9.00 | $24.52 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 5 |
| Target Price | $19.00 | ★ $23.49 |
| AVG Volume (30 Days) | ★ 405.8K | 333.9K |
| Earning Date | 05-13-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 7.77% |
| EPS Growth | N/A | ★ 50.00 |
| EPS | N/A | ★ 0.08 |
| Revenue | N/A | ★ $336,099,000.00 |
| Revenue This Year | N/A | $5.41 |
| Revenue Next Year | $25.91 | $3.33 |
| P/E Ratio | ★ N/A | $306.63 |
| Revenue Growth | N/A | ★ 11.27 |
| 52 Week Low | $5.05 | $20.56 |
| 52 Week High | $12.41 | $25.96 |
| Indicator | IMTX | DEA |
|---|---|---|
| Relative Strength Index (RSI) | 42.53 | 47.34 |
| Support Level | $8.62 | $24.35 |
| Resistance Level | $10.67 | $24.94 |
| Average True Range (ATR) | 0.45 | 0.59 |
| MACD | 0.00 | -0.06 |
| Stochastic Oscillator | 39.75 | 42.27 |
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
Easterly Government Properties Inc is a real estate investment trust. The company is engaged in the acquisition, development, and management of Class A commercial properties that are leased to U.S. government agencies. It generates all its revenue by leasing its properties to such agencies. The company operates in single segment for the purposes of assessing performance and making operating decisions.